| 29.95 Real-Time Quote |  +0.84 / +2.87%Today’s Change | 21.40 Today|||52-Week Range 29.95 | +19.40% Year-to-Date |
| Dow Today: Pfizer (PFE) Leads The Day Higher, Exxon Mobil Corporation (XOM) Lags 10:54am / TheStreet.com | Conditional EU Approval for Pfizer's Bosulif - Analyst Blog Apr 04 / Zacks.com |
| Generics: The Way Forward in India? - Analyst Blog Apr 05 / Zacks.com | Dow Today: Pfizer (PFE) Higher Apr 04 / TheStreet.com |
| Astra, Rigel Arthritis Pill Posts Mixed Trial Results Apr 05 / TheStreet.com | Trade These 5 Huge Stocks for Gains Apr 04 / TheStreet.com |
| Pharma & Biotech Stock Outlook - Apr 2013 - Industry Outlook Apr 04 / Zacks.com | Pfizer Stock Hits New 52-Week High (PFE) Apr 04 / TheStreet.com |
| Pharma & Biotech Stock Outlook - Apr 2013 - Zacks Analyst Interviews Apr 04 / Zacks.com | Pfizer Inks Nanotechnology Deal With BIND Therapeutics Apr 03 / MotleyFool.com |
| Previous close | 29.11 |
| Today’s open | 29.49 |
| Day’s range | 29.45 - 29.95 |
| Volume | 30,918,469 |
| Average volume (3 months) | 31,562,254 |
| Market cap | $209.2B |
| Dividend yield | 3.21% |
| Earnings growth (last year) | +17.43% |
| Earnings growth (this year) | +4.46% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -12.52% |
| P/E ratio | 23.7 |
| Price/Sales | 3.16 |
| Price/Book | 2.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis AG | +1.00 | +1.40% |
| MRKMerck & Co Inc | +1.43 | +3.14% |
| SNYSanofi SA | +0.57 | +1.11% |
| NVONovo Nordisk A/S | -0.57 | -0.34% |
| Next reporting date | April 30, 2013 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $59.0B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 16.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
President & General Manager-Emerging Markets Olivier Brandicourt, PhD, MD |
Corporate headquarters New York, New York |
.
